ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P1 Agonist and Functional Antagonist Potency In Vitro and In Vivo
出版年份 2021 全文链接
标题
ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P1 Agonist and Functional Antagonist Potency In Vitro and In Vivo
作者
关键词
-
出版物
MOLECULES
Volume 26, Issue 17, Pages 5134
出版商
MDPI AG
发表日期
2021-08-25
DOI
10.3390/molecules26175134
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis
- (2021) Faik Imeri et al. NEUROPHARMACOLOGY
- Suppressive Effect of CYM50358 S1P4 Antagonist on Mast Cell Degranulation and Allergic Asthma in Mice
- (2021) Wi-Jin Jeon et al. Biomolecules & Therapeutics
- Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Agonist
- (2021) Sekhar Surapaneni et al. DRUG METABOLISM AND DISPOSITION
- Loss of sphingosine kinase 2 enhances Wilm's tumor suppressor gene 1 and nephrin expression in podocytes and protects from streptozotocin-induced podocytopathy and albuminuria in mice.
- (2021) Faik Imeri et al. MATRIX BIOLOGY
- Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge
- (2020) Bisera Stepanovska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Morpholino Analogues of Fingolimod as Novel and Selective S1P1 Ligands with In Vivo Efficacy in a Mouse Model of Experimental Antigen-Induced Encephalomyelitis
- (2020) Bisera Stepanovska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects
- (2020) Jerold Chun et al. DRUGS
- Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases
- (2019) Bisera Stepanovska et al. PHARMACOLOGICAL RESEARCH
- Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models
- (2019) Kunio Sugahara et al. Journal of Immunology Research
- Internalization of G-protein-coupled receptors: Implication in receptor function, physiology and diseases
- (2018) Davide Calebiro et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Abnormal islet sphingolipid metabolism in type 1 diabetes
- (2018) Laurits J. Holm et al. DIABETOLOGIA
- The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives
- (2018) Andrea Huwiler et al. PHARMACOLOGY & THERAPEUTICS
- Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity
- (2016) F L Scott et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments
- (2016) Faik Imeri et al. NEUROPHARMACOLOGY
- Lysophospholipid receptor nomenclature review: IUPHAR Review 8
- (2014) Yasuyuki Kihara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice
- (2014) Faik Imeri et al. NEUROPHARMACOLOGY
- Desensitization by Progressive Up-Titration Prevents First-Dose Effects on the Heart: Guinea Pig Study with Ponesimod, a Selective S1P1 Receptor Modulator
- (2013) Markus Rey et al. PLoS One
- The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
- (2012) P Gergely et al. BRITISH JOURNAL OF PHARMACOLOGY
- Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
- (2011) M. Mehling et al. NEUROLOGY
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Efficient chromatography-free synthesis of the oxy-analogue of fingolimod
- (2010) Aleksandra Zivkovic et al. TETRAHEDRON LETTERS
- Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8
- (2009) Elmar Krieger et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- New players on the center stage: Sphingosine 1-phosphate and its receptors as drug targets
- (2008) Andrea Huwiler et al. BIOCHEMICAL PHARMACOLOGY
- Update of the LIPID MAPS comprehensive classification system for lipids
- (2008) Eoin Fahy et al. JOURNAL OF LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search